Blood Pressure Levels, Cardiovascular Events, and Renal Outcomes in Chronic Kidney Disease Without Antihypertensive Therapy: A Nationwide Population-Based Cohort Study.
Shujing WuMian LiJieli LuXulei TangGuixia WangRuizhi ZhengJingya NiuLi ChenYanan HuoMin XuTian-Ge WangZhi-Yun ZhaoShuangyuan WangHong LinGuijun QinLi YanQin WanLulu ChenLixin ShiRuying HuQing SuXuefeng YuYingfen QinGang ChenZhengnan GaoFeixia ShenZuojie LuoYuhong ChenYinfei ZhangChao LiuYoumin WangShengli WuTao YangQiang LiYiming MuJiajun ZhaoYanqiu WangYufang BiWeiqing WangYu Xunull nullPublished in: Hypertension (Dallas, Tex. : 1979) (2023)
In people with chronic kidney disease, a higher systolic BP/diastolic BP level (≥130/90 mm Hg) is significantly associated with a greater risk of cardiovascular and renal events, indicating potential thresholds to initiate BP-lowering treatment.
Keyphrases
- blood pressure
- cardiovascular events
- chronic kidney disease
- hypertensive patients
- coronary artery disease
- heart rate
- left ventricular
- cardiovascular disease
- end stage renal disease
- stem cells
- blood glucose
- skeletal muscle
- replacement therapy
- type diabetes
- adipose tissue
- combination therapy
- climate change
- glycemic control